JOURNAL OF CLINICAL MICROBIOLOGY

Scope & Guideline

Unveiling Innovations in Clinical Microbiology

Introduction

Explore the comprehensive scope of JOURNAL OF CLINICAL MICROBIOLOGY through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore JOURNAL OF CLINICAL MICROBIOLOGY in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN0095-1137
PublisherAMER SOC MICROBIOLOGY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1975 to 2024
AbbreviationJ CLIN MICROBIOL / J. Clin. Microbiol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1752 N ST NW, WASHINGTON, DC 20036-2904

Aims and Scopes

The Journal of Clinical Microbiology focuses on advancing the field of microbiology with a significant emphasis on clinical implications, diagnostics, and treatment outcomes related to infectious diseases. The journal aims to publish innovative research that enhances understanding of microbial pathogens and their interactions with hosts, particularly concerning antibiotic resistance and emerging infectious diseases.
  1. Clinical Microbiology and Infectious Diseases:
    The journal emphasizes research that elucidates the microbiological aspects of infectious diseases, including the characteristics of pathogens, their transmission dynamics, and the clinical implications of these infections.
  2. Antimicrobial Resistance and Stewardship:
    A significant focus on studies addressing antimicrobial resistance mechanisms, patterns of resistance, and the impact of antibiotic stewardship programs on clinical outcomes and resistance trends.
  3. Diagnostic Innovations:
    Research on the development and validation of novel diagnostic tools, including molecular methods and rapid testing techniques, to improve the identification of pathogens and guide effective treatment.
  4. Epidemiology and Public Health:
    Studies that explore the epidemiological patterns of infectious diseases, including outbreaks, risk factors, and the impact of public health interventions on disease control.
  5. Therapeutic Approaches and Treatment Outcomes:
    Investigation into the effectiveness of various therapeutic regimens, including novel antibiotics and combination therapies, and their outcomes in clinical settings.
The Journal of Clinical Microbiology is reflecting a shift in research trends, with emerging themes that are increasingly relevant in the context of global health challenges, particularly in light of recent pandemics and the rising threat of antimicrobial resistance.
  1. Metagenomics and Next-Generation Sequencing:
    There is a marked increase in studies utilizing metagenomics and next-generation sequencing technologies to understand complex microbial communities and their roles in health and disease.
  2. Impact of COVID-19 on Infectious Disease Epidemiology:
    Research examining the consequences of the COVID-19 pandemic on other infectious diseases, including changes in patterns of co-infections and the effects of public health measures on disease transmission.
  3. Antimicrobial Resistance Mechanisms:
    In-depth investigations into the genetic and biochemical mechanisms underlying antimicrobial resistance are on the rise, as understanding these mechanisms is crucial for developing effective treatment strategies.
  4. Telemedicine and Remote Diagnostics:
    Emerging research into the role of telemedicine and remote diagnostics in managing infectious diseases, particularly as healthcare systems adapt to the challenges posed by the COVID-19 pandemic.
  5. Infection Control and Prevention Strategies:
    A growing body of research focusing on infection control practices in healthcare settings, including the effectiveness of various interventions to reduce hospital-acquired infections.

Declining or Waning

While the Journal of Clinical Microbiology continues to thrive in various areas of research, certain themes have become less prominent over the recent years. This section highlights those waning scopes that may reflect changing priorities or advancements in related fields.
  1. Traditional Culture Methods:
    Research focusing on conventional culture methods for pathogen detection has seen a decline, likely due to the rise of molecular diagnostics and rapid testing technologies that offer quicker and more accurate results.
  2. Basic Research in Microbial Physiology:
    Studies that primarily focus on basic microbial physiology without direct clinical implications have decreased, as the journal leans more towards research with clear clinical applications and implications for patient care.
  3. Single Pathogen Focus Studies:
    Research that examines a single pathogen in isolation is less common, as there is a growing trend towards studying polymicrobial infections and the interactions between multiple pathogens in clinical settings.

Similar Journals

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Pioneering insights into microbial challenges.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Elevating discourse in microbiology and infection studies.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Exploring the frontiers of microbial research and clinical practice.
Publisher: EDICIONES DOYMA S AISSN: 0213-005XFrequency: 10 issues/year

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

New Microbiologica

Illuminating the intricate relationships between microbes and medicine.
Publisher: EDIZIONI INT SRLISSN: 1121-7138Frequency: 4 issues/year

New Microbiologica is a prominent academic journal published by EDIZIONI INT SRL, dedicated to advancing knowledge in the fields of Microbiology and Medicine. Since its inception in 1993, this journal has played a vital role in disseminating cutting-edge research, featuring articles that explore the intricate relationships between microorganisms and human health. With an H-index indicating a robust citation profile and a respectable 2023 Scopus Ranking placing it in the 32nd percentile for medicine microbiology, New Microbiologica resonates well within the academic community. Although not an Open Access journal, it is strategically positioned in Quartile 3 of both Medicine (miscellaneous) and Medical Microbiology categories, which reflects its importance to researchers and professionals seeking valuable insights in their fields. Published in Italy, the journal continues to provide a platform for impactful research through its commitment to high-quality publications, fostering collaboration and innovation among scientists and academics in the ever-evolving landscape of microbiological studies.

JOURNAL OF INFECTION AND CHEMOTHERAPY

Exploring Breakthroughs in Microbiology and Chemotherapy
Publisher: ELSEVIERISSN: 1341-321XFrequency: 6 issues/year

JOURNAL OF INFECTION AND CHEMOTHERAPY, published by Elsevier, is a leading journal in the fields of Infectious Diseases, Microbiology, and Pharmacology. With a solid reputation reflected in its prestigious Q2 ranking in Infectious Diseases and Pharmacology, and Q3 in Microbiology (medical), this journal serves as a vital resource for researchers, clinicians, and students interested in the latest advancements in the diagnosis, treatment, and prevention of infectious diseases. The journal provides a platform for high-quality, peer-reviewed scholarly articles, making it an essential reference point in the medical community. Despite being published without open access, it continues to attract significant scholarly attention, as denoted by its rankings in Scopus, which showcases its impact within the academic landscape. With a timeline converging from 1995 to 2024, JOURNAL OF INFECTION AND CHEMOTHERAPY is dedicated to advancing knowledge and contributing to better health outcomes globally.

Infectious Diseases

Transforming Discoveries into Solutions for Global Health
Publisher: TAYLOR & FRANCIS LTDISSN: 2374-4235Frequency: 12 issues/year

Infectious Diseases, published by TAYLOR & FRANCIS LTD, is a leading academic journal dedicated to advancing research in the field of infectious diseases and microbiology. With an impressive impact factor and categorized in Q1 in multiple areas including Immunology and Microbiology, this journal serves as a critical platform for researchers, practitioners, and students to disseminate their findings and stay abreast of current advancements. The journal is recognized for its rigorous peer-review process and aims to foster innovation and collaboration across disciplines from 2015 to 2024. It boasts a robust Scopus ranking, positioning it favorably among the top-tier of journals in the relevant fields, making it an essential resource for anyone involved in infectious disease research. Access options are available, ensuring that the latest research is accessible to a global audience, thus emphasizing the journal's commitment to promoting knowledge and understanding in the ever-evolving landscape of infectious diseases.

MIKROBIYOLOJI BULTENI

Exploring Innovations in Infectious Disease Research
Publisher: ANKARA MICROBIOLOGY SOCISSN: 0374-9096Frequency: 4 issues/year

MIKROBIYOLOJI BULTENI, with ISSN 0374-9096, is a prestigious academic journal published by the ANKARA MICROBIOLOGY SOC, located in Ankara, Turkey. Established in 1973, this journal has been a vital conduit for disseminating research in the fields of Immunology, Microbiology, and Infectious Diseases, garnering a reputation as a significant contributor to the scientific community. The journal is currently ranked in the Q3 category within Immunology and Microbiology (miscellaneous), and Infectious Diseases, indicating its impactful presence amidst contemporary research. With access options that may be restricted, MIKROBIYOLOJI BULTENI actively welcomes submissions that advance the understanding of critical microbiological principles and practices, thereby supporting both national and international research efforts. Researchers, professionals, and students are encouraged to explore the latest findings shared in this journal, as it continually shapes the landscape of microbiology and infectious disease studies through its comprehensive and rigorous peer-reviewed publications.

Current Clinical Microbiology Reports

Shaping Tomorrow's Practices in Microbial Health
Publisher: SPRINGERISSN: 2196-5471Frequency: 4 issues/year

Current Clinical Microbiology Reports, published by Springer, is a leading international journal dedicated to advancing the field of clinical microbiology. With a focus on the diagnosis, treatment, and prevention of infectious diseases, this journal serves as a vital resource for researchers, medical professionals, and students engaged in microbiological studies. As a testament to its quality and influence, it holds an impressive impact factor and ranks in the Q1 category in both Infectious Diseases and Microbiology (medical), reflecting its prominent standing in the scholarly community. Additionally, it features a commendable Scopus ranking, placing it in the 77th percentile for Medicine - Infectious Diseases and the 69th percentile for Medicine - Microbiology (medical). With contributions spanning over a decade, from 2014 to 2024, the journal continues to publish high-quality research articles that shape the future of clinical practices and public health policies. While access options are variable, the journal's commitment to open dialogue and dissemination of knowledge makes it a pivotal platform for those passionate about tackling microbial challenges in healthcare.

European Journal of Microbiology and Immunology

Enhancing Understanding of Microbial Diseases
Publisher: AKADEMIAI KIADO ZRTISSN: 2062-8633Frequency: 4 issues/year

Welcome to the European Journal of Microbiology and Immunology, a premier platform dedicated to advancing the field of microbiology and immunology through the dissemination of high-quality research. Published by AKADEMIAI KIADO ZRT in Hungary, this journal serves as an essential resource for researchers, professionals, and students alike, fostering scholarly communication and innovation in these critical areas of medical science. The journal, which holds an ISSN of 2062-8633, presents rigorously peer-reviewed articles that contribute to our understanding of microbial diseases, immune responses, and related fields, currently ranking in the Q2 and Q3 quartiles across multiple categories such as immunology and microbiology. By embracing an inclusive scholarly dialogue and offering a robust readership, the European Journal of Microbiology and Immunology aims to inspire the next wave of discoveries and collaborations within the global scientific community.

BMC MICROBIOLOGY

Connecting minds through groundbreaking microbiology insights.
Publisher: BMCISSN: 1471-2180Frequency: 1 issue/year

BMC Microbiology is a leading open access journal published by BMC, dedicated to advancing the field of microbiology since its inception in 2001. With an ISSN of 1471-2180, this journal provides a vital platform for researchers, professionals, and students to share and access high-quality research and innovation in both general and medical microbiology. Based in the United Kingdom, BMC Microbiology holds a commendable Q2 ranking in both various microbiological categories according to the 2023 Scopus rankings, indicating its strong influence in the microbiological community, with a rank of #47 out of 140 in Medical Microbiology and #62 out of 182 in general Microbiology. The journal's commitment to open access ensures that groundbreaking research is freely available to facilitate collaboration and knowledge sharing among the global community of microbiologists. With a focus on publishing original research, reviews, and case studies, BMC Microbiology plays a critical role in disseminating information that can impact health and environmental conditions around the world.